1. Home ›› 
  2. Notizie ›› 
  3. Rating ›› 

GlaxoSmithKline: Bofa Merrill Lynch alza rating da neutral a buy

FACEBOOK TWITTER LINKEDIN

GlaxoSmithKline: Bofa Merrill Lynch alza rating da neutral a buy.